금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stocks Rise Pre-Bell as Traders Await Fed Policy Decision, Inflation Report, Big Tech Earnings
The benchmark US stock measures pointed higher before the opening bell Monday as traders gear up for...
Stock market today: Dow, S&P 500, Nasdaq futures rise ahead of busy week of earnings, Fed rate decision
Investors braced for a full earnings docket and the Federal Reserve's next policy decision this week...
British Pound: Stronger PMIs lean hawkish for BoE – Danske Bank
Danske Research Team notes UK flash PMIs strengthened in October, with the composite rising to 53.1 ...
EUR/JPY Price Forecast: Rebound stalls below 200-day SMA
The EUR/JPY buyers stop the bleeding after three consecutive days of losses, registering modest gains of 0.56% on Tuesday. At the time of writing, the cross-pair trades at around 181.90 after US and J ...
USD/CHF Price Forecast: Trendline break puts 50-day SMA in focus
The USD/CHF retraced on Tuesday, down 0.16%, as the US Dollar weakened amid improved risk appetite, driven by renewed hopes of a US-Israel peace deal to open the Strait of Hormuz. The pair trades belo ...
VirTra, Inc. (VTSI) Increases Yet Falls Behind Market: What Investors Need to Know
VirTra, Inc. (VTSI) reached $3.11 at the closing of the latest trading day, reflecting a +1.63% change compared to its last close.
Pampa Energia GAAP EPS of $0.13 misses by $2.45, revenue of $746M misses by $19.64M
Chipotle pulls jalapenos from some locations after salmonella investigation. Here’s what to know.
While Chipotle’s stock slid on Tuesday, it said health investigators had “no ongoing concerns” with the chain after it removed the jalapenos.
Lowe's (LOW) Laps the Stock Market: Here's Why
Lowe's (LOW) concluded the recent trading session at $218.08, signifying a +2.84% move from its prior day's close.
Ulta Beauty (ULTA) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Ulta Beauty (ULTA) stood at $543.86, denoting a +1.77% move from the preceding trading day.
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand.
Tyra Biosciences GAAP EPS of -$0.69 misses by $0.04
Stocks face their weakest seasonal stretch. Why extreme investor pessimism could limit any selling.
U.S. stocks are entering what has historically been the weakest stretch of the year, but unusually bearish investor sentiment could help limit any pullback, according to Ned Davis Research.
Novo Nordisk Raises Earnings Guidance. The Stock Sinks.
The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight loss and Ozempic for diabetes.
IYF vs EUFN: U.S. and European Financial Giants Face Off in this ETF Comparison
Europe's financials fund yields 4.0% but carries deeper drawdown risk, while its U.S. counterpart offers broader diversification with 142 holdings.